Maureen Achebe is an Oncology physician affiliated with Brigham and Women's Hospital. OpenAlex indexes 15 publications with 1,214 citations (h-index 10).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
75 Francis Street
Brigham And Womens Hospital Hematology Division
Boston, MA 02115
Telephone
617-732-5048Registry record last updated 31 Jan 2018.
Industry payments
7 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Pharmacosmos Therapeutics Inc.Program year20251 payment
- VERTEX PHARMACEUTICALS INCORPORATEDProgram year20251 payment
- VERTEX PHARMACEUTICALS INCORPORATEDProgram year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
52.3%Opioid Agonist52.3%Oxycodone Hcl31%Hydromorphone Hcl27%Methadone Hcl22%Morphine Sulfate Er20%Part D<11 patientsBlood & clotting
31.4%Factor Xa inhibitor31.4%Eliquis69%Xarelto32%Part D<11 patientsCancer & immunology
16.3%Antimetabolite16.3%Hydroxyurea100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- A systematic literature review and meta-analysis of the incidence of serious or severe hypersensitivity reactions after administration of ferric derisomaltose or ferric carboxymaltose
International Journal of Clinical Pharmacy
2023 - Long‐term biological effects in sickle cell disease: insights from a post‐crizanlizumab study
British Journal of Haematology
2021
Similar KOLs
Other experts from the same institution or the same specialty.
Paul Ridker, MD
Brigham and Women's Hospital
Scott Solomon, MD
Brigham and Women's Hospital
Dennis Selkoe, MD
Brigham and Women's Hospital
Marc Pfeffer, MD
Brigham and Women's Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”